STOCK TITAN

Pacific Biosciences Grants Equity Incentive Award to New Employee

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Pacific Biosciences (NASDAQ: PACB) announced on September 24, 2021, that its Compensation Committee granted stock options for 100,000 shares and restricted stock units (RSUs) for 50,000 shares to a new employee. These awards are part of the 2020 Inducement Equity Incentive Plan, introduced to attract new talent. The stock options have an exercise price of $27.99, equal to the stock's closing price on the grant date. The vesting schedule includes milestones at one year and monthly thereafter for options, while RSUs vest over four years.

Positive
  • Granting 100,000 stock options and 50,000 RSUs may enhance employee retention and motivation.
  • The use of the 2020 Inducement Plan indicates a strategic approach to attract key talent.
Negative
  • None.

MENLO PARK, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of Pacific Biosciences common stock, and restricted stock units (“RSUs”) covering 50,000 shares of Pacific Biosciences common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan (the “2020 Inducement Plan”) effective on September 20, 2021.

The 2020 Inducement Plan is used exclusively to grant equity awards to individuals who were not previously an employee or non-employee director of Pacific Biosciences as an inducement material to such individual’s entering into employment with Pacific Biosciences in accordance with Nasdaq Marketplace Rule 5635(c)(4).

The options have an exercise price of $27.99 per share, which is equal to the closing price of Pacific Biosciences common stock on September 20, 2021 (the “Effective Date”). The shares subject to the option shall be scheduled to vest and become exercisable as to 1/4th of the total number of shares subject at grant to the Option on the one (1) year anniversary of the Effective Date and as to 1/48th of the total shares subject at grant to the Option each month thereafter on the same day of the month as the Effective Date (or the last day of the month, if a particular month does not have a corresponding day). The RSUs shall be scheduled to vest as to 1/4th of the total number of shares subject at grant to the RSUs on each of the one (1), two (2), three (3), and four (4) year anniversaries of the Effective Date. The option grant and the award of restricted stock units are subject to the terms and conditions of the 2020 Inducement Plan and the award agreements entered into with the non-executive officer employee.

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.

Contacts Investors:
Todd Friedman 650.521.8450
ir@pacificbiosciences.com

Media:
Jen Carroll 858.449.8082
pr@pacificbiosciences.com


FAQ

What recent employee compensation changes did PACB announce?

PACB announced the granting of stock options for 100,000 shares and restricted stock units (RSUs) for 50,000 shares to a new employee.

What is the exercise price for the newly granted stock options by PACB?

The exercise price for the stock options is $27.99 per share, matching the stock's closing price on the grant date of September 20, 2021.

What is the vesting schedule for the stock options granted by PACB?

The stock options will vest 1/4th on the one-year anniversary and then monthly at 1/48th thereafter.

How do the RSUs vest for the new employee at PACB?

The RSUs will vest at a rate of 1/4th on each of the one, two, three, and four-year anniversaries of the grant date.

Pacific Biosciences of California, Inc.

NASDAQ:PACB

PACB Rankings

PACB Latest News

PACB Stock Data

499.80M
268.70M
1.85%
83.09%
18.5%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
MENLO PARK